Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1004 participants
OBSERVATIONAL
2008-07-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Angio-Seal Interventional Radiology (IR) Registry
NCT01222104
St. Jude Medical Angio-Seal VIP Vascular Closure Device
NCT01393041
The Complete® Self-Expanding Stent and Stent Delivery System Registry
NCT00730730
RESOLUTE ONYX Post-Approval Study
NCT03063749
Driveline Silicone Skin Interface Registry
NCT01577433
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
St. Jude Medical
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Applegate, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Good Samaritan Hospital
Los Angeles, California, United States
Michigan Heart, P.C.
Ypsilanti, Michigan, United States
Cooper Health System
Camden, New Jersey, United States
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
Altru Health System Hospital
Grand Forks, North Dakota, United States
Ohiohealth Research Institute @ Riverside Methodist Hospital
Columbus, Ohio, United States
Providence Health & Services
Portland, Oregon, United States
Main Line Health Heart Center: Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, United States
Main Line Health Heart Center: Lankenau Hospitals
Wynnewood, Pennsylvania, United States
Baptist Hospital West
Knoxville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Applegate RJ, Turi Z, Sachdev N, Ahmed A, Szyniszewski A, Foster M, Pratsos A, Shapiro T, Yakubov S, Shavelle D. The Angio-Seal Evolution registry: outcomes of a novel automated Angio-Seal vascular closure device. J Invasive Cardiol. 2010 Sep;22(9):420-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0801
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.